Coin Press - Strike fears rise over Iran

NYSE - LSE
CMSD -0.57% 22.8 $
CMSC 0.13% 22.77 $
RBGPF -4.99% 60.52 $
RELX 5.23% 34.6 $
RYCEF -4.9% 17.16 $
BCE -0.2% 25.06 $
NGG -1.91% 80 $
RIO 2.36% 108.96 $
VOD 0.07% 14.97 $
GSK -2.49% 49.31 $
BCC -1.71% 68.33 $
BTI -1.3% 61 $
JRI -2.05% 12.66 $
AZN -3.32% 179.71 $
BP 2.49% 42.94 $

Strike fears rise over Iran




For weeks, diplomacy has been moving in step with mobilisation. Now, the two are beginning to collide. In the past month, the United States has quietly assembled a posture in and around the Gulf that looks less like routine “deterrence” and more like readiness: the sort of layered force mix designed to survive first contact, sustain operations, and manage escalation if an initial strike fails to end a crisis. Israel, still bruised by the consequences of its last major exchange with Iran, has been calibrating its own preparedness—publicly insisting it will not tolerate a rebuilt Iranian nuclear capability, while privately bracing for retaliation should Washington pull the trigger.

Iran, meanwhile, is behaving like a state that believes war is plausible even as it negotiates: hardening sensitive sites, dispersing assets, projecting defiance at home and abroad, and seeking to extract concessions at the negotiating table without conceding what it regards as sovereign rights. The result is a familiar but dangerous pattern: talks under threat, force under ambiguity, and a region where a single misread signal can become irreversible.

A deadline that turns talks into an ultimatum
Diplomacy has resumed through indirect channels, with meetings hosted by regional intermediaries and later shifting to a European venue for further contacts. The core dispute remains unchanged: the United States is pressing for a far tighter ceiling on Iran’s nuclear activities—up to and including an end to enrichment—while Iran insists that any arrangement must recognise its right to a peaceful nuclear programme and deliver meaningful economic relief. The novelty is not the substance, but the tempo. Washington has been coupling the talks to a time-bound warning: an explicit window of days, not months, for Iran to accept terms. By design, such a clock does two things at once. It increases pressure on Tehran, narrowing the space for protracted bargaining. And it compresses decision-making in Washington itself, forcing the White House to choose between accepting an imperfect agreement, extending the deadline (and absorbing the political cost), or acting militarily.

That compression matters because nuclear negotiations are not purely technical. Every clause—verification access, stockpile limits, centrifuge restrictions, sequencing of sanctions relief—becomes a proxy for trust, and trust is precisely what is absent. Tehran remembers the collapse of earlier arrangements and doubts that any American undertaking will outlast political cycles. Washington, for its part, doubts that Iranian transparency will ever be sufficient to rule out a “threshold” capability—the ability to assemble a weapon quickly should a decision be taken. In such conditions, the deadline is less a diplomatic instrument than a strategic signal: it tells Iran that the United States is prepared to shift from coercion-by-sanctions to coercion-by-strike.

What “limited” could mean—and why planners prepare for more
Publicly, American language has left open the notion of a “limited” strike—an operation framed as narrow, finite, and aimed at nuclear infrastructure or enabling military systems. Privately, military planning reportedly assumes a more complicated reality: that even a restrained opening move could trigger a prolonged sequence of actions and reactions. There are practical reasons for that caution. Iran’s nuclear programme is not a single target. It is a network of facilities, capabilities, personnel, and supply chains—some above ground, others buried; some declared, others suspected. A truly “limited” strike that achieves strategic effect would need to do more than crater buildings. It would have to degrade specialised equipment, disrupt command-and-control, blunt air defences, and impede Iran’s ability to reconstitute what was lost. That logic tends to expand target lists.

Then there is the second-order problem: retaliation. Even if Tehran avoids a full-scale conventional response, it retains multiple pathways to impose costs—through missile or drone attacks on regional bases, harassment of shipping, cyber operations, or action by aligned non-state actors. A “limited” operation can therefore become weeks of force protection, counter-strikes, and crisis management, even if neither side formally declares war.

This is why Washington’s posture-building has emphasised depth rather than symbolism: carrier-based aviation to generate sustained sorties; additional combat aircraft to widen options and reduce dependence on any single base; intelligence, surveillance and reconnaissance to locate mobile launchers and dispersing assets; missile defence to blunt the most predictable forms of retaliation; and logistical throughput to sustain tempo if the first wave is not the last.

The anatomy of a build-up
The US military’s regional footprint is designed for flexibility, but the current concentration has been notable in both scale and composition. Naval forces have been moving into theatre with the kind of redundancy that suggests planners are hedging: not merely “presence”, but the ability to surge, absorb attrition, and maintain operations over time. Air assets have also been repositioned, including stealth-capable platforms and supporting aircraft needed for extended operations—tankers for refuelling, early warning systems to coordinate airspace, and specialised reconnaissance to locate targets that do not stay still.

Such moves are rarely announced as preparation for attack. They are described instead as “reassurance” of allies, “deterrence” of escalation, and “defence” of regional interests. Yet the difference between deterrence and readiness is not rhetorical; it is logistical. When large quantities of equipment and personnel arrive on tight timelines, and when plans are discussed in terms of sustained operations rather than short punitive raids, it becomes harder to treat the build-up as merely precautionary.

For regional states hosting American forces, this creates a delicate dilemma. Hosting provides security guarantees; it also makes them potential targets. Some will press Washington privately to keep any operation brief. Others will press for maximal damage to Iran’s capabilities, arguing that half-measures invite future crises. Either way, their geography ties them to the outcome.

Israel’s calculus: opportunity, fear, and the problem of follow-through
Israel’s security establishment has been preparing for the possibility that the United States will strike—and that Iranian retaliation will be directed at Israel regardless of whether Israel participates in the initial blow. The expectation is not simply that missiles might fly, but that Iran would seek an outcome that restores deterrence: a demonstration that attacks on Iranian soil carry immediate regional costs.

Israel also faces a strategic paradox. It wants the Iranian nuclear programme stopped or rolled back decisively. But it also knows that partial damage can be worse than none if it leads Iran to rebuild faster, deeper, and more covertly, with domestic legitimacy reconstituted through wartime mobilisation. This is why Israeli debate often pivots on a blunt question: if the programme cannot be ended outright, what is the objective of force? Delay, degradation, or destruction? Each goal demands different levels of escalation and different tolerances for regional fallout.

In parallel, Israel has continued to articulate conditions it believes any diplomatic arrangement should meet: deep restrictions on enrichment and stockpiles; curbs on missile ranges; an end to support for armed partners across the region; and a halt to internal repression that, in Israel’s view, fuels instability and radicalisation. Iran rejects such bundling as an attempt to turn nuclear negotiations into a referendum on its entire security doctrine. Here, too, the danger is sequencing. If Washington and Israel appear aligned on maximalist demands that Iran will not accept, the “deadline” becomes not a pressure tactic but a glide path to conflict.

Iran’s counter-moves: hardening, dispersal, and a negotiating stance under fire
Iran has responded to the rising threat environment in ways consistent with a state that expects air power. Sensitive facilities have been fortified and further protected, including through physical hardening—measures intended to complicate targeting, reduce damage, and slow follow-on assessments. Such efforts are not, by themselves, proof of weaponisation; they are, however, evidence that Tehran is trying to preserve programme survivability under the assumption that strikes are possible.

At the same time, Iran has signalled that it is preparing a counterproposal in the talks—an attempt to show engagement while defending its red lines. Those red lines are widely understood in Tehran: no permanent end to enrichment; no negotiation of its ballistic missile programme; and no wholesale abandonment of regional partnerships that Iran frames as deterrence and strategic depth.

This position is sharpened by domestic vulnerability. Iran has faced significant internal unrest and a harsh state response. Under such pressure, concessions that appear imposed by foreign threats can be politically toxic. A leadership worried about legitimacy at home may therefore be more willing to endure external risk than to accept a deal portrayed as capitulation. That dynamic complicates American calculations. The more the United States emphasises coercion—deadlines, threats, military options—the more it may strengthen the internal argument in Tehran that compromise is dangerous, and that only resilience preserves sovereignty.

Why the next phase could be more dangerous than the last
The most unstable period in crises of this kind is often the final stretch before a decision—when signals are plentiful, interpretations multiply, and each side tries to shape the other’s psychology. For Washington, the danger is that a “limited” strike produces an “unlimited” problem: not regime collapse, not capitulation, but a drawn-out campaign of defence, retaliation management, and incremental escalation. For Israel, the danger is that even a successful American operation leaves Iran wounded but capable—angry enough to retaliate, intact enough to rebuild, and determined enough to push its most sensitive work further underground.

For Iran, the danger is that hardening and dispersal are interpreted as sprinting towards a threshold, prompting attack; while restraint is interpreted as weakness, inviting further coercion. Tehran’s leadership may believe that showing preparedness deters war. Washington may read the same actions as evidence that time is running out. Layered on top of these strategic dynamics is the simplest risk of all: miscalculation. Aircraft and ships operating in crowded theatres, missiles and drones on alert, proxy forces with their own incentives, and domestic political pressures that reward toughness—each increases the probability that an incident becomes a trigger.

In public, all parties still speak the language of prevention: preventing a nuclear-armed Iran, preventing regional war, preventing escalation. In practice, prevention is being pursued through instruments that can themselves create the very catastrophe they are meant to avoid. The world has been here before. The difference now is that the military pieces are moving more visibly, the timelines are shorter, and the political space for stepping back is narrower. In that environment, the question is not only whether a strike is imminent, but whether any actor still has enough room—and enough restraint—to keep it from becoming inevitable.



Featured


Long live Ukraine - Хай живе Україна - Да здравствует Украина

Es lebe die Ukraine - Да здравствует Украина - Long live Ukraine - Хай живе Україна - Nech žije Ukrajina - Länge leve Ukraina - תחי אוקראינה - Lang leve Oekraïne - Да живее Украйна - Elagu Ukraina - Kauan eläköön Ukraina - Vive l'Ukraine - Ζήτω η Ουκρανία - 乌克兰万岁 - Viva Ucrania - Ať žije Ukrajina - Çok yaşa Ukrayna - Viva a Ucrânia - Trăiască Ucraina - ウクライナ万歳 - Tegyvuoja Ukraina - Lai dzīvo Ukraina - Viva l'Ucraina - Hidup Ukraina - تحيا أوكرانيا - Vivat Ucraina - ขอให้ยูเครนจงเจริญ - Ucraina muôn năm - ژوندی دی وی اوکراین - Yashasin Ukraina - Озак яшә Украина - Živjela Ukrajina - 우크라이나 만세 - Mabuhay ang Ukraine - Lenge leve Ukraina - Nyob ntev Ukraine - Да живее Украина - გაუმარჯოს უკრაინას - Hidup Ukraine - Vivu Ukrainio - Længe leve Ukraine - Živjela Ukrajina - Жыве Украіна - Yaşasın Ukrayna - Lengi lifi Úkraína - Lank lewe die Oekraïne

Stargate project, Trump and the AI war...

In a dramatic return to the global political stage, former President Donald J. Trump, as the current 47th President of the United States of America, has unveiled his latest initiative, the so-called ‘Stargate Project,’ in a bid to cement the United States’ dominance in artificial intelligence and outpace China’s meteoric rise in the field. The newly announced programme, cloaked in patriotic rhetoric and ambitious targets, is already stirring intense debate over the future of technological competition between the world’s two largest economies.According to preliminary statements from Trump’s team, the Stargate Project will consolidate the efforts of leading American tech conglomerates, defence contractors, and research universities under a centralised framework. The former president, who has long championed American exceptionalism, claims this approach will provide the United States with a decisive advantage, enabling rapid breakthroughs in cutting-edge AI applications ranging from military strategy to commercial innovation.“America must remain the global leader in technology—no ifs, no buts,” Trump declared at a recent press conference. “China has been trying to surpass us in AI, but with this new project, we will make sure the future remains ours.”Details regarding funding and governance remain scarce, but early indications suggest the initiative will rely heavily on public-private partnerships, tax incentives for research and development, and collaboration with high-profile venture capital firms. Skeptics, however, warn that the endeavour could fan the flames of an increasingly militarised AI race, raising ethical concerns about surveillance, automation of warfare, and data privacy. Critics also question whether the initiative can deliver on its lofty promises, especially in the face of existing economic and geopolitical pressures.Yet for its supporters, the Stargate Project serves as a rallying cry for renewed American leadership and an antidote to worries over China’s technological ascendancy. Proponents argue that accelerating AI research is paramount if the United States wishes to preserve not just military supremacy, but also the economic and cultural influence that has typified its global role for decades.Whether this bold project will succeed—or if it will devolve into a symbolic gesture—remains to be seen. What is certain, however, is that the Stargate Project has already reignited debate about how best to safeguard America’s strategic future and maintain the balance of power in the fast-evolving arena of artificial intelligence.

Fentanyl trade unravels

Fentanyl, a synthetic opioid up to 50 times more powerful than heroin, has been at the centre of a catastrophic overdose crisis. After years of relentless expansion, the market that once claimed tens of thousands of lives annually is contracting. Preliminary data from the United States Centers for Disease Control and Prevention (CDC) indicate that estimated drug overdose deaths fell to about 80,000 in 2024, a 27 per cent decline from the record of more than 110,000 in 2023, signalling the largest one‑year drop in modern history. This article examines why the fentanyl business is faltering, exploring the interlocking impacts of supply‑chain disruption, international diplomacy, law‑enforcement operations and public‑health initiatives.From Peak to DownturnDuring the early 2020s, illicitly manufactured fentanyl flooded the North American drug market, becoming the leading cause of overdose deaths. The pandemic exacerbated the situation: social isolation and disrupted addiction treatment services contributed to a spike of nearly 110,000 U.S. overdose deaths in 2023. Most of those deaths involved fentanyl, which dealers used to replace or adulterate heroin, counterfeit prescription pills and cocaine. Yet by 2024 the tide had turned. CDC data show that overdose deaths fell by roughly 30,000 in one year, and preliminary numbers for 2025 suggest the decline is continuing. The decrease extends across most U.S. states, with notable reductions in Ohio and West Virginia. Such a sustained downward trend had not been seen in decades and prompted researchers to look beyond domestic policy interventions for an explanation.Supply‑Chain Disruption and China’s CrackdownOne of the most significant drivers of the decline appears to be a disruption in the global supply of fentanyl and its precursors. Researchers analysing death trends in the United States and Canada found evidence of a sudden shortage of fentanyl on illicit markets beginning in mid‑2023. A Science journal study led by scholars at Stanford and the University of Maryland concluded that Chinese enforcement actions against chemical suppliers have curtailed exports of fentanyl precursors. Officials in Beijing shut down hundreds of companies, removed tens of thousands of online advertisements and arrested about 300 people after agreements with Washington to restrict the trade. The research suggests these moves reduced the availability of 4‑fluoroisobutyryl fentanyl and other precursors, causing the purity of seized fentanyl to fall and the price to rise. According to the DEA’s 2025 National Drug Threat Assessment, some Chinese suppliers have become wary of shipping controlled chemicals, aware that their government is enforcing updated counter‑narcotics treaties. Mexican fentanyl cooks report difficulty obtaining key precursors and are increasingly relying on designer chemicals to circumvent regulations.Cartel Disruption and EnforcementWhile precursor shortages have choked production, targeted law‑enforcement operations have also shaken the industry. White papers from the National Security Data and Policy Institute detail how the capture of Ovidio Guzmán López — a senior Sinaloa Cartel figure and son of Joaquín "El Chapo" Guzmán — in 2023 destabilised the cartel’s synthetic‑drug division. Experts point to a correlation between cartel ‘decapitation’ operations and sharp but temporary declines in fentanyl seizures and overdose deaths. The killing of Nemesio Oseguera Cervantes, leader of the Jalisco New Generation Cartel in late 2025, likewise rattled the market, although researchers caution that rival factions can quickly reconstitute production. The National Drug Threat Assessment notes that the Sinaloa and Jalisco cartels continue to dominate fentanyl production, but they face greater risk as Mexican and U.S. authorities cooperate to target laboratories and intercept shipments at the southwest border. Seizures at border crossings dropped from 29,000 kilograms in 2023 to 23,000 kilograms in 2024, reinforcing evidence of a supply contraction.Public‑Health Measures and Changing BehaviourThe contraction of the fentanyl trade has amplified the effect of public‑health interventions. Increased distribution of the overdose‑reversal drug naloxone, expansion of medication‑assisted treatment programmes and billions of dollars in opioid settlement funds have collectively improved survival rates. Harm‑reduction services such as supervised consumption sites and drug‑checking kits have proliferated in major cities, allowing users to detect dangerous adulterants like xylazine and medetomidine. Younger Americans appear less likely to initiate opioid use than previous cohorts, and some long‑term users have died or shifted consumption patterns. These behavioural changes mean that a shrinking pool of susceptible individuals is exposed to an increasingly fragmented drug supply.An Evolving Drug MarketDespite the current downturn, the illicit drug market is far from static. The DEA warns that declining fentanyl purity does not equate to reduced danger. To compensate for shortages, traffickers are mixing fentanyl with veterinary tranquilizers and new synthetic opioids such as nitazenes, which can be even more potent. The National Security Data and Policy Institute notes that precursor chemicals still arrive in Mexico’s Pacific ports such as Manzanillo, and cartels are diversifying sourcing through India and alternative trans‑shipment points. According to the DEA, the presence of xylazine in seized powder has risen steadily since 2020, increasing the risk of fatal respiratory depression and flesh‑rotting wounds. Nitazene analogues and other novel substances are appearing in toxicology reports at an accelerating rate in 2026, underscoring how quickly manufacturers pivot when confronted with enforcement pressure.The sharp decline in fentanyl‑related deaths offers a glimmer of hope after years of escalating tragedy, but it is not a definitive victory. The current contraction appears to be driven primarily by disruptions in precursor supply, strategic cartel‑targeting operations and strengthened public‑health responses. Yet the same agility that allowed traffickers to flood markets with fentanyl enables them to adapt to enforcement, shifting to new chemicals, routes and business models. Sustained reductions in opioid mortality will require international cooperation to control chemical exports, continued pressure on manufacturing networks, wider access to treatment and harm‑reduction services, and public education to deter drug initiation. As policy makers debate how to allocate resources, the lesson of the fentanyl collapse is clear: comprehensive, co‑ordinated action across borders and disciplines can save lives.